baber/WOPTO huggingface dataset:
Patent DK-168462-B1 (DK)
Title: Moisture indicator
Inventor: ALASAARELA ESKO
IPC: G01N21/43
Filed: 1988-05-27
Granted: 1994-03-28
Abstract: The invention relates to an optical device for measuring moisture in a substrate, in which device water is conveyed from the substrate along a porous absorption part (5) on a surface (4) of a prism so that is causes the critical angle of the total reflection to be changed thereon as a result of the change of the index of refraction. Another surface of the prism is dyed or patterned and covered in such a manner that it becomes visible only through reflection from the surface (4) when the surface is dry. When the surface (4) is moist, only the absorption part is visible through the viewing surface. The invention is advantageous in that due to the application of the principle of total reflection the change from an indication of the presence of moisture to an indication of the absence of moisture takes place sharply, not gradually.
Patent DK-168128-B1 (DK)
Inventor: HILTEBRAND EDUARD
IPC: F16K1/226
Filed: 1988-08-16
Granted: 1994-02-14
Abstract: In a flap valve, a casing is provided forming a flow opening through the valve. A flap is pivotally mounted in the casing for closing the flow opening. The casing is formed of two annular parts secured together by bolts. The two casing parts have a plane of contact with a seal secured between the two parts and extending around the opening in the plane of contact. The seal includes a pair of spaced rings with arcuately shaped seal members extending between and interconnecting the rings. Each seal member has an circumferentially extending closed hollow space forming an air cushion. When the flap is placed in the closed position in the flow opening, a slight torsional moment is executed against the seal which is formed of a wear-resistant material so that a good sealing effect is obtained.
Patent FI-104083-B1 (FI)
Inventor: LUCIANI LUCIANO
IPC: C08F4/60
Filed: 1992-07-08
Granted: 1999-11-15
Abstract: A solid component of catalyst for the (co)polymerization of ethylene is composed of a silica support and of a catalytically active part containing titanium, magnesium, chlorine and alkoxy groups, and is obtained by:   (i) activating a silica support by contact with a solution of magnesium dialkyl, or magnesium alkyl chloride, in a liquid, aliphatic hydrocarbon solvent; (ii) impregnating the activated silica with a solution, in a liquid aliphatic or aromatic ester, of titanium tetrachloride and tetra-alkoxide in equimolecular or almost equimolecular quantities, and magnesium chloride; and (iii) treating the solid obtained in step (ii) with a proportioned quantity of aluminium alkyl sesquichloride. p
Patent FI-102482-B1 (FI)
Inventor: HAECKER HANS-EUGEN
IPC: D03C3/38
Filed: 1993-11-12
Granted: 1998-12-15
Abstract: Adjustable harness guide for the Jacquard machine (1) of a seam-weaving loom, in which the harness cords (3) are retracted by tension springs (6) which are fastened in a grid (7), and the harness cords (3) are guided through a harness board (8), the shed being located between the grid (7) and the harness board (8), and the grid (7) and the harness board (8) being adjustable in their angular positions relative to the run of the harness cords (3). The grid (7) and the harness board (8) can be connected by means of a linkage (21), so that they move in synchronism. The grid (7) and the harness (8) can each consist of two halves connected to one another by means of a hinge (12, 13), the axis of the hinge (12, 13) extending parallel to the warp threads of the seam shed. <IMAGE>
Patent IE-33494-B1 (IE)
Title: Cycloalkano-quinolone derivatives
IPC: C07D221/08
Filed: 1969-07-21
Abstract: 1,210,638. Cycloalkano-quinoline derivatives. BOEHRINGER MANNHEIM G.m.b.H. [21 July, 1969 [23 July, 1968; 14 March, 1969], No. 36601/69. Heading C2C. Novel cycloalkano-quinoline derivatives of the Formula I wherein one of the symbols R 1 and R 2 represents H halogen, NO 2 , NH 2 , OH, acylamino, acyloxy, alkoxy or aryloxy, while the other one, together with R 3 , forms an aliphatic bridge containing 2-6 carbon atoms, X is H, C 1-4 alkyl or C 2-4 alkenyl, and Y is OH, NH 2 or C 1-4 alkoxy and pharmacologically compatible salts thereof are prepared by cyclising a cycloalkano-benzene derivative of Formula II above, in which Y<SP>1</SP> is alkoxy or NH 2 , whereafter, if desired, the products obtained are saponified, esterified, transesterified or converted into amides, and/or the substituents R 1 or R 2 are introduced or chemically changed and/or, when X is H, the product is N-alkylated. Ethyl α - ethoxycarbonyl- # - (4 - indanylamino)-acrylate, ethyl α-ethoxycarbonyl-#-(5- indanylamino)acrylate, ethyl α - ethoxycarbonyl- # - (1,2,3,4 - tetrahydronaphthyl - 6 - amino) acrylate and ethyl α-ethoxycarbonyl-#- (1,2,3,4- tetrahydronaphthyl-5-amino) acrylate are obtained by reacting diethyl. ethoxymethylenemalonate with 4-aminoindane, 5-aminoindane, 6 - amino - 1,2,3,4 - tetrahydronaphthalene and 5 - -amino - 1,2,3,4 - tetrahydronaphthalene respectively. Pharmaceutical compositions, having antimicrobial activity, contain at least one of the above novel compounds in admixture with solid or liquid pharmaceutical diluents or carriers.
[GB1210638A]
Patent IE-57749-B1 (IE)
Title: Process for preparation of alkanoic acids
IPC: C07C59/56
Filed: 1984-04-27
Abstract: A process for preparing substituted acetic acids of the general formula I:wherein R represents a hydrogen atom or an alkyl radical C1-C4 and Ar represents an aromatic nature radical chosen from the following radicals: 2-thienyl, 2-methoxy-naphthyl-1, 3,4-methylenedioxy phenyl, and substituted phenyl of the general formula II:wherein R1 represents a hydrogen atom or an alkyl group C1-C4 and R2 represents a hydrogen atom, a halogen atom, an alkyl, alkoxyl or hydroxyl, characterized in that is reacted in hot, in an acid medium, in the presence of phosphoretouge, and catalytic amounts of iodine or hydroiodic acid, carboxylic acid alpha carbonyl of the general formula III:wherein R has the above meaning, with an unsaturated derivative of aromatic nature selected from the following: thiophene, 2-methoxy naphthalene, 1,2-methylenedioxy benzene and substituted aromatic hydrocarbons of the general formula IV:wherein R1 and R2 have the above meanings, optionally in a compatible organic solvent.
Patent IE-52819-B1 (IE)
Title: Device and process for the production of cheese curd
IPC: A23C19/05
Filed: 1982-05-04
Abstract: Cheese curd is produced by coagulating a milk product during its passage through a long coagulator tube under renneting conditions giving a relatively slow coagulation course. The milk product is renneted in-line and the renneted mixture is fed periodically to the inlet end of the coagulator tube. The feeding periods are separated by stand still periods, the feeding period duration being selected so that there is substantially no coagulation of the mixture introduced until the next stand still period, and the duration of the stand still periods being selected so that the mixture after one stand still period in the coagulator tube forms a sufficiently firm coagulum to be transported as a continuous plug by feeding new mixture to the tube during a subsequent feeding period. The speed of feeding mixture into the coagulator tube and the length of the coagulator tube are adjusted so that the residence time in the coagulator tube comprises at least one feeding period and one stand still period. A device for carrying out the invention comprises a long tube of constant cross-section having a length/ diameter ratio greater than 500, and an envelope enclosing the tube for maintaining the temperature of the mixture in the tube substantially constant.
Patent IE-39293-B1 (IE)
Title: Method for determination of the presence of antibiotics
IPC: G01N33/02
Filed: 1974-05-29
Abstract: A method for the rapid determination of the presence or absence of residues of antibiotic such as penicillin, in liquids, for example milk, and meat comprising introducing spores of a microorganism which possesses a high sensitivity for the antibiotic to be determined into an agar medium so that the spores are prevented from starting to germ due to lack of nutrients, but stay alive, and being sufficiently heavily inoculated that after addition of nutrients and incubation at or near optimal temperature in a short time sufficient growth has proceeded so that growth is either observable visually or its indicated by an indicator added to the agar medium, the said spore culture being allowed to solidify in upright test vessels having a cross-sectional dimension sufficiently small to require as little of the agar medium as possible but sufficiently large to enable a correct determination of inhibition of growth of the microorganism to be made, and having a height so that the vessel can contain a sufficient amount of medium and a sufficient amount of sample of liquid to be tested, placing on the agar surface nutrients required for growth, followed, if desired, after a pre-incubation period, by addition of a predetermined amount of sample liquid to be tested to the test vessel, and incubating the contents of the test vessel at or near optimal temperature for a predetermined time so that the extent of growth or inhibition of growth of the microorganism read in a vertical sense, indicates absence or presence of the antibiotic.
[US3941658A]
Patent IE-35742-B1 (IE)
Title: Method and apparatus for the preparation of homogeneous meterable pastes and suspensions of phthalic acids and glycols for feeding plants more particularly continuous esterification plants
IPC: C08G63/78
Filed: 1971-10-18
Abstract: 1374623 Mixing SNIA VISCOSA SOC NAZIONALE INDUSTRIA APPLICAZION I VSCOSA SpA 21 Oct 1971 [12 Oct 1970] 49047/71 Heading B1C Apparatus, e.g. for forming a homogeneous paste from terephthalic acid and ethylene glycol as a stage in polyester production comprises a vessel 10, means 22, 24 for feeding metered quantities of the materials to be mixed into the vessel 10, mechanical mixing means 12, means 26 for continuously removing the paste, and heat removing means for limiting the mixing temperature to not above 50‹C. The mixing means 12 may comprise vertical blades 12' driven by a motor 14, cooling water, e.g. at 15‹C being circulated through a jacket 16 with an inlet 18 and outlet 20. The paste, removed by a valve 26 and pump 28 may be recirculated through conduits 30, 32, 34 provided with sampling means 38, while pumps 42, 44 provided with valves 46, 48 control flow through a duct 50, e.g. to an esterification reactor.
[GB1374623A]
Patent IE-50876-B1 (IE)
Title: Vehicle for conveying in bulk powdered,granular or fragmented material
IPC: B60P3/22
Filed: 1980-07-28
Abstract: A vehicle (9) with many hoppers (11) for bulk material has a common discharge pipe (1) and a special closing member (19) in the discharge funnel (8), which is such that in closed position the discharge pipe (1) offers little flow resistance to the passing mixture of air and material.
Patent IE-66676-B1 (IE)
Title: Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
Inventor: FERRONE SOLDANO
IPC: C07K16/00
Filed: 1989-05-17
Abstract: This invention discloses two novel anti-idiotypic antibodies, IMelpg1 and MF11-30 and equivalents thereof, as well as, antibody fragments, peptides or antisera capable of reacting with the idiotope of: (a) murine monoclonal antibody 225.28 and derivatives thereof; or with (b) any monoclonal antibody secreted by hybridomas from any species having the same immunological characteristics as antibody 225.28; or with (c) any polyclonal antisera from any species having the same immunological characteristics as antibody 225.28, capable of reacting with a specific determinant (epitope) of a high molecular weight-melanoma associated antigen are described, together with their preparation and use in the diagnosis, monitoring and treatment of tumors such as melanoma or other diseased cells which express the HMW-MAA epitope recognized by antibody 225.28.
Patent IE-33679-B1 (IE)
Title: 3-(3,4-dihydroxyphenyl)-alanine
IPC: C07C227/36
Filed: 1969-12-23
Abstract: 1292975 Preparation of L-Dopa and novel intermediates F HOFFMANN-LA ROCHE & CO 16 Dec 1969 [27 Dec 1968] 61248/69 Heading C2C L - 3 - (3,4 - Dihydroxyphenyl) - alanine is prepared by treating a racemate of formula wherein R<SP>1</SP> and R<SP>2</SP> individually represent a hydroxy, lower alkoxy, acyloxy or phenyl- (lower alkoxy) group or R<SP>1</SP> and R<SP>2</SP> together represent a lower alkylenedioxy group and R<SP>3</SP> represents an acyl group, with an optically active resolving agent of the general formula R<SP>4</SP>(R<SP>5</SP>)CHNH 2 , wherein R<SP>4</SP> represents a phenyl or naphthyl group or a substituted derivative thereof, and R<SP>5</SP> represents a lower alkyl group, to form the corresponding diastereomeric salts, separating these salts, converting the salts of the L-antipode into L-3-(3,4-dihydroxyphenyl) -alanine and, if desired, racemizing the D-antipode and leading the racemate back into the process, where lower denotes groups containing 1 to 7 C atoms. The L-isomers of the salts of Formula III: wherein R<SP>1</SP> to R<SP>5</SP> are as above and the free L- acids of formulµ wherein R'<SP>1</SP> and R'<SP>2</SP> are C 1-7 alkoxy or R'<SP>1</SP> and R'<SP>2</SP> together represent a methylenedioxy group, and R"<SP>1</SP> and R''<SP>2</SP> are each OH, C 1-7 alkoxy, phenyl (C 1-7 )-alkoxy or acyloxy, are claimed as novel compounds.
[GB1292975A]
Patent IE-58951-B1 (IE)
Title: Solid pharmaceutical preparations for oral administration containing 9-deoxo-11-deoxy-9, 11-(IMINO(2-(2-methoxyethoxy)ethylidene)-oxy)-(9s)-erythromycin and processes for the preparation thereof
IPC: A61P31/04
Filed: 1986-07-09
Abstract: There is described a solid pharmaceutical preparation for oral administration which produces high and long-lasting blood and tissue levels, containing 9-deoxo-11-deoxy-9,11-[imino[2-(2-methoxyethoxy)-ethylidene]oxy]-(9S)- erythromycin as active substance, in which the active substance must be intimately mixed with a basic excipient in a ratio of 1 mol of active substance to at least 2 gram-equivalents of basic excipient, and the preparations are coated with a gastric juice-resistant lacquer which is soluble in a pH range of between 5.5 and 6.8, and processes for preparing them. The solid pharmaceutical preparations include tablets, pellets or granules and a syrup can be produced from the latter.
Patent IE-41693-B1 (IE)
Title: Light transmitting panel and method of manufacturing such panel
IPC: E06B3/67
Filed: 1975-09-12
Abstract: 1511921 Glazing B F G GLASSGROUP 15 Sept 1975 [16 Sept 1974 (2) 27 Dec 1974 (3) 1 Feb 1975 4 April 1975] 37866/75 Heading E1R A light transmitting panel comprises panes spaced by more than 9 mm, the space containing a gas comprising at least 30% by volume of air; the velocity of sound in the gas differing by at least 5% from that in air. The gas may include SF 6 , CCl 2 F 2 , CO 2 , A, C 4 H 10 , N 2 O, or C 2 ClF 5 , for lower sound velocity or He, Ne, CH 4 , or H 2 for higher velocity. The panes may be of different thicknesses. Three panes may be used, the two spaces being inter-connected or containing gases with different sound propagation velocities. A space may communicate with a desiccant. The panes may have coatings of metal or oxide.
Patent IE-69314-B1 (IE)
Title: Novel anti-epileptics
Inventor: CHRISTIAN MARESCAUX
IPC: C07F9/30
Filed: 1991-06-21
Abstract: Compounds having GABAB-antagonistic properties, for example those of formula I    <IMAGE>  (I)  wherein one of the radicals R1, R2 and R3 is hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another is hydrogen or, in the case of R1 or R2, hydroxy or, in the case of R1, halogen or, in the case of R2 together with R2', oxo, and the remaining radical is hydrogen, R1' is hydrogen or halogen, R2' is hydrogen, hydroxy or, together with R2, is oxo, R4 and R5 are hydrogen or R4 is an araliphatic or heteroarylaliphatic radical and R5 is hydrogen or an aliphatic radical, and R is an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, araliphatic, heteroarylaliphatic or aromatic radical having at least 2 carbon atoms or, when R1 is hydrogen or hydroxy, R2 is an aromatic radical and R1', R2' and R3 are hydrogen, R is methyl, and their pharmaceutically acceptable salts, can be used as active ingredients in medicaments for the treatment of epilepsies of the "petit mal"  type. The invention relates also to novel compounds of formula I and processes for the preparation thereof.
Patent IE-41764-B1 (IE)
Title: Cyclopropane carboxylic aicd derivatives
IPC: C07C51/00
Filed: 1974-10-22
Abstract: 1465568 Racemic or optically active derivatives of cyclopropane carboxylic acid ROUSSEL UCLAF 22 Oct 1974 [22 Oct 1973] 45653/74 Headings C2C and C2P The invention relates to racemic or optically active derivatives of cyclopropane carboxylic acid of cis or trans structure of Formula I in which R represents either a R 1 group which is either hydrogen, or an alkali metal atom, or an alkyl radical containing from 1 to 6 carbon atoms, substituted if necessary, or a R 2 group which is either a benzyl radical, substituted, if necessary, by one or more substituents selected from an alkyl, an alkenyl, an alkadienyl, a methylenedioxy, a benzyl radical and a halogen atom, or a cyclohexene dicarboximide methyl radical having a double bond at any position in the hexagonal nucleus and, if necessary, substituted on the said hexagonal nucleus by one or more halogen atoms, one or more methyl radicals or one or more acetoxy radicals, or a radical of formula in which Y 1 and Y 2 , the same or different, represent hydrogen, an alkyl, alkenyl or alkadienyl radical and Y 3 represents hydrogen, an alkyl, alkenyl, alkadienyl, alkynyl, or aryl radical or a heterocyclic radical, all these radicals being capable, if necessary, of being substituted, or a 1-oxo 2-Z 3-methyl 2-cyclopentene 4-yl residue of formula in which Z represents an alkyl, alkenyl, alkynyl, aryl, aralkyl, cycloalkyl, or cycloalkenyl radical or a heterocyclic radical. The compounds have insecticidal properties. Compounds of the general Formula I in which R is H are prepared by reacting 2,2-dimethyl 3- formyl cyclopropane 1-carboxylic acid, the configuration of which at the 1- and 3-positions is the same as that desired in the product, with a phosphonate or phosphorane containing a 1- ethyl propane-2-one 1-yl chain in the presence of a strong base. Suitable phosphonates include, for example, O,O-dialkyl alpha-ethyl acetonyl phosphonate and a suitable phosphorane is, for example, an alpha-ethyl acetonyl triaryl phosphorane, e.g. alpha-ethyl acetonyl triphenyl phosphorane. Compounds of the general Formula I in which R is other than H or an alkali metal atom are prepared by reacting a compound of Formula I wherein R represents hydrogen or an alkali metal (or a functional derivative thereof) with a compound of formula XOH (or a functional derivative thereof) wherein X represents a group R 2 or an optionally substituted alkyl group. When R represents hydrogen then this acid may, if desired, be used in the form of, for example, its acid chloride, anhydride, mixed anhydride or a salt. The alcohol of formula XOH may, for example, be used in the form of a halide derivative of formula X-Hal or an alkali metal derivative. Alpha-ethyl-acetonyltriphenylphosphorane is prepared by reacting propyltriphenyl phosphonium iodide with ethyl thioacetate. Dipropyl alphaethyl acetonylphosphonate is produced by reacting tripropyl phosphonate and ethyl acetate.
Patent IE-45820-B1 (IE)
Title: Shuttle type livestock feeder
Inventor: SMITH KENNETH L
IPC: B65G21/12
Filed: 1977-10-27
Abstract: Process for preparing thymosin alpha 1 from thymosin fraction 5 by chromatography on dextran gels as well as on carboxymethyl cellulose and 2-diethylaminoethyl cellulose using gradient elution. Thymosin alpha 1 possesses immunostimulatory properties.
Patent IE-49222-B1 (IE)
Title: Non-plastic hydraulic cement mixes and process for improving such mixes
IPC: C04B24/12
Filed: 1979-12-03
Abstract: A method is provided for improving the strength and other properties of non-plastic dry hydraulic cement mixes. such as the dry concrete mixes used for making concrete masonry units The methods comprises incorporating a synergistic combination of two additives into the cement mix. The first additive is a salified methyl or ethyl substituted benzene or naphthalene sulfonate, and is preferably added in an amount of between about 0.01 and 1%, by weight based upon the weight of the cement. The second additive is a tertiary aliphatic amine oxide, and is preferably added in an amount of between 0.001 and 0 1%
Patent IE-59939-B1 (IE)
Title: Controlled release device for an active substance
IPC: A61K9/22
Filed: 1987-09-03
Abstract: A device for the controlled release of a substance having useful activity into a fluid medium at a substantially constant rate, said substance contained in a shape which is substantially that of a truncated cone by means of an impermeable wall or coating on the base and side (but not the top) of said truncated cone. Apparatus useful in manufacture when said device is a tablet for administration to a mammal.
Patent IE-48665-B1 (IE)
Title: Isolation of hepatitis be antigen
IPC: C07K16/00
Filed: 1979-12-11
Abstract: Hepatitis B e antigen or hepatitis B e antibody are separated from human biological fluid by centrifugation in a density gradient and isolated in the 1.04-1.15 g/cc density region.
Patent IE-42319-B1 (IE)
Title: Intra-uterine gynacelogical device
IPC: A61F6/14
Filed: 1974-12-05
Abstract: 1495735 Intrauterine contraceptive SCHERING AG 6 Dec 1974 [6 Dec 1973 18 Jan 1974 1 June 1974] 52961/74 Headings A5B and A5R A Y-shaped intrauterine contraceptive is formed of synthetic plastics material and has a rounded head 5, 6 at the end of each of its branches 3, 4 respectively and a plurality of rounded enlargements 1, 10-13 spaced along its stem, the angle between the branches and that between each branch and the stem being obtuse and the resilience of the contraceptive being such that the branches can be brought into substantially axial alignment with the stem. The heads 5, 6 and enlargements 1, 10-13 may be substantially spherical. A pharmacologically active substance may be incorporated in or on the contraceptive for gradual release into the uterus. This substance may comprise a metal e.g. copper, silver or nickel, which may be applied as a coating to one or more of the spheres, and the coating may comprise a plurality of layers, successive layers being of different metals. Alternatively the metal may be in particulate form and distributed throughout a sphere. The substance may alternatively have a hormonal or gestagenic activity and may be a steroid. It may also have a local anaesthetic or weakly basic buffering action. The substance may be dispersed in the plastics or be included in a core member inserted in at least one sphere. The contraceptive may be inserted into the uterus using a tubular inserter 16 containing a rigid member 17 connected to an elongate member 14 at the base of the stem by a severable cord 18. A filament 19 for location in the cervical canal may be connected to member 14, which filament may also be provided with the pharmacologically active substance.
Patent IE-47767-B1 (IE)
Title: Improvements in or relating to closures
IPC: B65D41/44
Filed: 1978-12-21
Abstract: A tear tab closure for containers comprises a cap having a top, a downwardly depending skirt, a tear tab projecting from the skirt and terminating in a finger ring. The tear tab is relatively short and the finger ring is secured thereto by any suitable mechanical or adhesive fastening means. The finger ring is of large enough inside diameter to facilitate capture of the finger ring by a finger of the user and it may be disposed to lie at the side of the container or it may be large enough in diameter to encircle the container in close proximity thereto.